Company Announcements

Publication of a Prospectus

Source: RNS
RNS Number : 3243F
RELX PLC
06 March 2020
 

Publication of Prospectus

The following prospectus has been approved by the FCA:

Prospectus dated 6 March 2020 (the "Prospectus") relating to the €700,000,000 0.000 per cent. Guaranteed Notes due 2024, €800,000,000 0.500 per cent. Guaranteed Notes due 2028 and €500,000,000 0.875 per cent. Guaranteed Notes due 2032 (together, the "Notes") of RELX Finance B.V., guaranteed by RELX PLC.

To view the Prospectus, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/3243F_1-2020-3-6.pdf

A copy of the Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at http://www.morningstar.co.uk/uk/NSM 

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

In particular, the Prospectus does not constitute an offer of securities for sale in the United States. The Notes referred to therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or under any relevant securities laws of any state of the United States of America and may not be offered or sold to U.S. persons or to persons within the United States of America.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PDIZQLFBBXLBBBX